Browse All

Current Filters

CLEAR FILTER x

TITLE

Effect of Zilucoplan on Myasthenia Gravis–Specific Outcome Subdomain Scores in RAISE: A Phase 3 Study

Author:Weiss, Michael D.   Farmakidis, Constantine   Freimer, Miriam   Genge, Angela   Hewamadduma, Channa   Hussain, Yessar   Leite, M. Isabel   Maniaol, Angelina   Utsugisawa, Kimiaki   Vu, Tuan   Boroojerdi, Babak   Grimson, Fiona   Savic, Natasa   Howard Jr., James F.   

Session Name:S34: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S34.004  

Author Institution:Department of Neurology, University of Washington Medical Center, Seattle, WA, USA, Seattle, WA  Department of Neurology, Neuromuscular Division, University of Kansas Medical Center, Kansas City, KS, USA, Kansas City, KS  Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA, Columbus, OH  Clinical Research Unit, The Montreal Neurological Institute, Montreal, QC, Canada, Montreal, QC, Canada  Academic Neuroscience Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK  Sheffield Institute for Translational Neurosciences (SITraN), University of Sheffield, Sheffield, UK , Sheffield, United Kingdom  Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA, Austin, TX  Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK, Oxford, United Kingdom  Department of Neurology, Oslo University Hospital, Oslo, Norway, Oslo, Norway  Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan, Hanamaki, Japan  Department of Neurology, University of South Florida Morsani College of Medicine, Tampa, FL, USA, Tampa, FL  UCB, Monheim, Germany, Monheim, Germany  UCB, Slough, UK, Slough, United Kingdom  UCB, Bulle, Switzerland, Bulle, Switzerland  Department of Neurology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA, Chapel Hill, NC  

Phase 3 Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy and Safety Results in Patients with Generalized MG

Oral Cladribine Capsules for Generalized Myasthenia Gravis: Design of the Actively Recruiting Phase 3 MyClad Study